All Stories

  1. D-galactose-conjugated thiazole-thiourea hybrids: Synthesis, in vitro inhibition against DPP-4 and PTP1B, their molecular docking, molecular dynamics simulations and DFT calculations
  2. Maltose-Conjugated Thiosemicarbazones from Substituted Benzaldehydes: Synthesis and Inhibitory Activity against Gram-(+) and Gram-(−) Bacteria
  3. d -Galactose-conjugated pyrimidine thioureas as potent antimicrobial agents: rapid green synthesis, structure–activity relationships and molecular modelling
  4. Synthesis and Biological Activity for 1,3,4‐Thiadiazole–2‐Iminothiazolidin‐4‐Ones: Antidiabetic and Anti‐Alzheimer Activity
  5. Substituted D‐Galactose‐Conjugated Thiazole‐Thioureas Derivatives as Promising Antidiabetic Agents: Synthesis, In Vitro Inhibition, and Molecular Simulation for α‐Amylase, α‐Glucosidase, Protein Glycation, and Oxidative Stress
  6. d-Glucose-Conjugated Benzo[d]thiazole–thiazolidin-4-one Hybrids: Design and Synthesis as Multitarget Anti-Alzheimer Compounds
  7. D-glucose-conjugated thioureas containing 2-aminopyrimidine as potential multitarget inhibitors for type 2 diabetes mellitus: Synthesis and biological activity study
  8. Sulphonyl thiourea compounds containing pyrimidine as dual inhibitors of I, II, IX, and XII carbonic anhydrases and cancer cell lines: synthesis, characterization and in silico studies
  9. Synthesis, antiproliferative activity, ADMET, molecular docking, molecular dynamics simulation, and DFT study for coumarin-based 1,5-benzothiazepines
  10. Lactose-conjugated 2-iminothiazolidin-4-ones: synthesis, inhibitory activity and molecular simulations as potential inhibitors against enzymes responsible for type 2 diabetes
  11. Sulfonyl thiourea derivatives from 2‐aminodiarylpyrimidines: In vitro and in silico evaluation as potential carbonic anhydrase I, II, IX, and XII inhibitors
  12. Sulfonyl thioureas with a benzo[d]thiazole ring as dual acetylcholinesterase/butyrylcholinesterase and human monoamine oxidase A and B inhibitors: An in vitro and in silico study
  13. Design, synthesis, inhibitory activity, and molecular simulations study for d-glucose-conjugated thioureas containing pyrimidine ring as multitarget inhibitors against α-amylase, α-glucosidase, DDP-4, and PTP1B in Type 2 diabetes mellitus
  14. Synthesis, anticancer activity, and molecular simulation of N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thioureas containing a pyrimidine ring
  15. Substituted isatin-thiosemicarbazones containing d-galactose moiety: Synthesis, antimicrobial inhibition assay and molecular simulation study
  16. Synthesis and Potential Dual Inhibitory Activity Against Acetylcholinesterase and Butyrylcholinesterase of Galactose‐Conjugated Isatin β‐Thiosemicarbazones
  17. Design, synthesis, molecular docking study and molecular dynamics simulation of new coumarin-pyrimidine hybrid compounds having anticancer and antidiabetic activity
  18. Glyco-conjugated thiosemicarbazones of substituted isatin containing D-galactose moiety: Synthesis, bacterial/fungal inhibition assay and molecular docking study
  19. Synthesis and in vitro anticancer activity of 4H-pyrano[2,3-d]pyrimidine−1H-1,2,3-triazole hybrid compounds bearing D-glucose moiety with dual EGFR/HER2 inhibitory activity and induced fit docking study
  20. Synthesis and inhibitory activity against MurA and MurZ enzymes of 4H-pyrano[2,3-d]pyrimidine–1H-1,2,3-triazole hybrid compounds having piperidine and morpholine rings
  21. Thiourea derivatives containing 4-arylthiazoles and d-glucose moiety: design, synthesis, antimicrobial activity evaluation, and molecular docking/dynamics simulations
  22. Synthesis, antimicrobial activity and molecular simulation of thiourea derivatives containing 6-carboalkoxybenzo[d]thiazole andd-glucose moieties
  23. Synthesis, biological and molecular modelling for 1,3,4-thiadiazole sulfonyl thioureas: bacterial and fungal activity
  24. Design, Synthesis, α‐Amylase/α‐Glucosidase Inhibition Assay, Induced Fit Docking Study of New Hybrid Compounds Containing 4H‐Pyrano[2,3‐d]pyrimidine, 1H‐1,2,3‐Triazole and D‐Glucose Components
  25. 1H‐1,2,3‐Triazole−4H‐chromene−D‐glucose hybrid compounds: Synthesis and inhibitory activity against Mycobacterium tuberculosis protein tyrosine phosphatase B
  26. Synthesis, bacterial and fungal inhibition assay, molecular docking study of substituted isatin (N-substituted 1,2,3,4-tetra-O-acetyl-β-glucopyranosyl)thiosemicarbazones
  27. Synthesis, Cytotoxicity, ADMET and Molecular Docking Studies of Some Quinoline-Pyrimidine Hybrid Compounds: 3-(2-Amino-6-arylpyrimidin-4- yl)-4-hydroxy-1-methylquinolin-2(1H)-ones
  28. Synthesis and antiproliferative activity of 1H-1,2,3-triazole-4H-chromene-d-glucose hybrid compounds with dual inhibitory activity against EGFR/VEGFR-2 and molecular docking studies
  29. Synthesis, biological evaluation and induced fit docking simulation study of d-glucose-conjugated 1H-1,2,3-triazoles having 4H-pyrano[2,3-d]pyrimidine ring as potential agents against bacteria and fungi
  30. A Double-Edged Sword: Thioxanthenes Act on Both the Mind and the Microbiome
  31. Synthesis and antiproliferative activity of hybrid thiosemicarbazone derivatives bearing coumarin and d-galactose moieties with EGFR inhibitory activity and molecular docking study
  32. Study on synthesis of some substituted N-propargyl isatins by propargylation reaction of corresponding isatins using potassium carbonate as base under ultrasound- and microwave-assisted conditions
  33. N-(2,3,4,6-tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones of 6-alkoxy-2-oxo-2H-chromene-4-carbaldehydes: synthesis, evaluation of their antibacterial, anti-MRSA, antifungal activity, and docking study
  34. Novel thiazoline–coumarin hybrid compounds containing sugar moieties: synthesis, biological evaluation and molecular docking study as antiproliferative agents
  35. Substituted 4-Formyl-2H-chromen-2-ones: Their Reaction with N-(2,3,4,6-Tetra-Oacetyl- β-D-galactopyranosyl)thiosemicarbazide, Antibacterial and Antifungal Activity of Their Thiosemicarbazone Products
  36. Synthesis of 6- and 7-alkoxy-4-methylcoumarins from corresponding hydroxy coumarins and their conversion into 6- and 7-alkoxy-4-formylcoumarin derivatives
  37. Synthesis of some 1H-1,5-benzodiazepine Series Containing Chromene Ring from α,β-Unsaturated Ketones of 6-Acetyl-5-Hydroxy-4-Methylcoumarin
  38. Synthesis, cytotoxic activity, ADMET and molecular docking study of quinoline-based hybrid compounds of 1,5-benzothiazepines
  39. Efficient click chemistry towards novel 1H-1,2,3-triazole-tethered 4H-chromene−d-glucose conjugates: Design, synthesis and evaluation of in vitro antibacterial, MRSA and antifungal activities
  40. Synthesis and structure of some substituted 2-amino-4-aryl-7-propargyloxy-4H-chromene-3-carbonitriles
  41. Synthesis, biological evaluation and molecular docking study of 1,2,3-1H-triazoles having 4H-pyrano[2,3-d]pyrimidine as potential Mycobacterium tuberculosis protein tyrosine phosphatase B inhibitors
  42. THE ANTIDEPRESSANT DRUG DOXEPIN: A PROMISING ANTIOXIDANT
  43. Reaction of Some Substituted 3-Aryl-4-formylsydnones with Tetra-Oacetyl- β-D-galactopyranosyl)thiosemicarbazide
  44. Possibilities of developing novel potent antitumor agents from the leaves of <em>Cryptomaria japonica</em>
  45. Synthesis and evaluation of in vivo antioxidant, in vitro antibacterial, MRSA and antifungal activity of novel substituted isatin N- (2,3,4,6-tetra- O -acetyl-β -d- glucopyranosyl)thiosemicarbazones
  46. Ionic Liquids as Catalyst for Synthesis of Some Aromatic Peracetylated N-(β-DGlucopyranosyl) Thiosemicarbazones
  47. Synthesis of Some Novel Substituted Benzaldehyde N-(2,3,6,2´,3´,4´,6´ - Hepta-O-Acetyl-β-D-Lactosyl)thiosemicarbazones
  48. Synthesis and Characterization of Some Novel Thiosemicarbazones of Substituted Benzaldehydes and N-(Hepta-O-Acetyl-β-d-Lactosyl)Thiosemicarbazide
  49. <strong>SYNTHESIS OF SOME (HEPTA-O-ACETYL-</strong><strong>b</strong><strong>-LACTOSYL)THIOSEMICARBAZONES CONTAINING AROMATIC NUCLEUS WITH IONIC LIQUID AS CATALYST</strong>
  50. SYNTHESIS OF 2-AMINOTHIAZOLIDIN-4-ONES FROM (HEPTA<em>-O-</em>ACETYL-b-MALTOSYL)THIOSEMICARBAZONES OF SUBSTITUTED ACETOPHENONES
  51. Synthesis and antibacterial and antifungal activities of N-(tetra-O-acetyl-β-d-glucopyranosyl)thiosemicarbazones of substituted 4-formylsydnones
  52. ChemInform Abstract: Study on Synthesis of 2‐(Substituted benzylidene) amino‐2‐deoxy‐1,3,4,6‐tetra‐O‐acetyl‐β‐D‐glucopyranones from D‐Glucosamine.
  53. Study on Synthesis of 2-(Substituted Benzylidene)amino-2-Deoxy-1,3,4,6- Tetra-O-Acetyl-β-D-Glucopyranoses from D-Glucosamine
  54. A comparative Analysis of In Vitro and In Vivo Efficacies of the Enantiomers of Thioridazine and Its Racemate
  55. Role of Phenothiazines and Structurally Similar Compounds of Plant Origin in the Fight against Infections by Drug Resistant Bacteria
  56. Antioxidant activities of thiosemicarbazones from substituted benzaldehydes and N-(tetra-O-acetyl-β-d-galactopyranosyl)thiosemicarbazide
  57. Reaction ofN-alkylisatins with 4-(2,3,4,6-tetra-O-acetyl-β-D-glucopyranosyl)thiosemicarbazide
  58. Synthesis of Some Peracetylated Glucopyranosyl Thiosemicarbazones of Substituted 4-Formylcoumarins
  59. A rapid LC–ESI-MS/MS method for the quantitation of choline, an active metabolite of citicoline: Application to in vivo pharmacokinetic and bioequivalence study in Indian healthy male volunteers
  60. ChemInform Abstract: Microwave‐Assisted Synthesis of Novel Tetra‐O‐acetyl‐β‐D‐glucopyranosyl Thiosemicarbazones of Substituted Isatins.
  61. Synthesis of Peracetylatedβ-D-Glucopyranosyl Thioureas from Substituted 2-Aminobenzo-1ʹ, 3ʹ-thiazoles
  62. Synthesis, structure and antioxidant activity of (tetra-O-acetyl-β-D-galactopyranosyl)thiosemicarbazones of substituted benzaldehydes
  63. Antimicrobial Activity of New Coumarin Derivatives
  64. Evidence of significant synergism between antibiotics and the antipsychotic, antimicrobial drug flupenthixol
  65. Microwave-Assisted Synthesis of Novel Tetra-O-acetyl-β-D-glucopyranosyl Thiosemicarbazones of Substituted Isatins
  66. New Patentable Use of an Old Neuroleptic Compound Thioridazine to Combat Tuberculosis: A Gene Regulation Perspective
  67. Reaction ofN-(Per-O-acetyl-β-D-glucopyranosyl)-Nʼ-(4ʼ,6ʼ-diarylpyrimidine-2ʼ-yl)thioureas with Ethyl Bromoacetate
  68. Thioridazine protects the mouse from a virulent infection by Salmonella enterica serovar Typhimurium 74
  69. Microwave-Assisted Synthesis of Acetophenone (per-O-acetylated-β-D-glucopyranosyl)thiosemicarbazones
  70. Experimental analyses of synergistic combinations of antibiotics with a recently recognised antibacterial agent, lacidipine
  71. Activity of the phenothiazine methdilazine alone or in combination with isoniazid or streptomycin against Mycobacterium tuberculosis in mice
  72. Synthesis of N-tetra-O-acetyl-β-d-glucopyranosyl-N′-(4′,6′-diarylpyrimidin-2′-yl)thioureas
  73. The anti-inflammatory non-antibiotic helper compound diclofenac: an antibacterial drug target
  74. Phase transfer catalyzed synthesis of bis-quinolines: Antileishmanial activity in experimental visceral leishmaniasis and in vitro antibacterial evaluation
  75. In vitro and in vivo efficacies of amlodipine against Listeria monocytogenes
  76. Potential role of non-antibiotics (helper compounds) in the treatment of multidrug-resistant Gram-negative infections: mechanisms for their direct and indirect activities
  77. Activity of diclofenac used alone and in combination with streptomycin against Mycobacterium tuberculosis in mice
  78. Potential management of resistant microbial infections with a novel non-antibiotic: the anti-inflammatory drug diclofenac sodium
  79. Isolation and identification of a flavone (quercetin) from Butea frondosa bark
  80. Antimicrobial potentiality of the thioxanthene flupenthixol through extensive in vitro and in vivo experiments
  81. Antibacterial property of the antipsychotic agent prochlorperazine, and its synergism with methdilazine
  82. In Vitro and in Vivo Antimicrobial Action of Tea: The Commonest Beverage of Asia
  83. In Vitro and In Vivo Synergism between Tetracycline and the Cardiovascular Agent Oxyfedrine HCl against Common Bacterial Strains
  84. Antimycobacterial activity of the antiinflammatory agent diclofenac sodium, and its synergism with streptomycin
  85. Antibacterial potentiality of Mesua ferrea Linn. flowers
  86. Triflupromazine: a microbicide non-antibiotic compound
  87. Evaluation of Synergism between the Aminoglycoside Antibiotic Streptomycin and the Cardiovascular Agent Amlodipine
  88. Experimental Analysis of Antimicrobial Action of Dicyclomine Hydrochloride
  89. Studies on the antibacterial potentiality of isoflavones
  90. EVALUATION OF IN VITRO AND IN VIVO ANTIBACTERIAL ACTIVITY OF DOBUTAMINE HYDROCHLORIDE
  91. Evaluation of a synergistic combination between the non-antibiotic microbicides diclofenac and trifluoperazine
  92. Antimicrobial potentiality of a new non-antibiotic: the cardiovascular drug oxyfedrine hydrochloride
  93. Experimental Studies on Synergism Between Aminoglycosides and the Antimicrobial Antiinflammatory Agent Diclofenac Sodium
  94. Trifluoperazine: a broad spectrum bactericide especially active on staphylococci and vibrios
  95. Screening for anti-HIV drugs that can combine virucidal and virustatic activities synergistically
  96. The anti-bacterial action of diclofenac shown by inhibition of DNA synthesis
  97. In VitroandIn VivoAntimicrobial Action of Fluphenazine
  98. Antimycobacterial activity of methdilazine (Md), an antimicrobic phenothiazine
  99. Possible Human Health Hazards from Outbreak of Epizootic Ulcerative Syndrome (EUS) in Fish in the Asia-Pacific Region
  100. Immunochemical studies on Shigella dysenteriae type 10 bacterial polysaccharide
  101. Immunochemical studies on a polysaccharide from Shigella dysenteriae type 2
  102. Structural studies on a polysaccharide from Shigella dysenteriae type 7
  103. Single bacteriocin typing scheme for the vibrio group of organisms
  104. Incidence and Elimination of R Plasmids in Vibrio cholerae
  105. Antibacterial Activity of Ambodryl and Benadryl
  106. Transformation with Bacteriocin Factors in Staphylococci
  107. Paradoxical Inhibition among Bacteria. Characterization of the Phenomenon and Nature of the Genetic Process